TNFα blockade in human diseases: An overview of efficacy and safety

This publication has 117 references indexed in Scilit:

• Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trial
  Journal of Dermatological Treatment, 2007
• Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
  Annals of the Rheumatic Diseases, 2006
• Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
  Journal of the American Academy of Dermatology, 2006
• Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register
  Arthritis & Rheumatism, 2006
• Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
  JAMA, 2006
• Infliximab in the treatment of extra‐intestinal manifestations of Crohn's disease
  Scandinavian Journal of Rheumatology, 2005
• Off-Label Dermatologic Uses of Anti-TNF-a Therapies
  Journal of Cutaneous Medicine and Surgery, 2005
• Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis
  American Journal of Gastroenterology, 2004
• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• Rational Use of Disease-Modifying Antirheumatic Drugs
  Drugs, 1990